A case report describes a patient with pregnancy-associated atypical hemolytic uremic syndrome harboring a coagulation factor ...

Novastra Therapeutics, a clinical-stage biotechnology company developing a novel category of cancer immune therapy, reported ...

CAP: a 350-patient pivotal trial of a sepsis device that selectively removes the DNA immune traps driving organ failure.

Previous studies have shown that upon antigen stimulation, the T cell receptor (TCR) undergoes phase separation with the ...

Explore how childhood trauma may affect stress physiology, metabolism, inflammation, and gut-brain health, contributing to treatment-resistant anxiety and OCD.

Jena, Germany, Oct. 27, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced its events ...

Kidney transplantation remains the most effective treatment for end-stage kidney disease; however, long-term graft survival is constrained by rejection and chronic graft injury, and donor shortages ...

The complement system, a sprawling network of plasma and membrane-bound proteins long regarded as little more than a first-response killing machine against microbes, is now recognized as one of the ...

Preeclampsia is a multifactorial, pregnancy-related disorder characterized by new-onset hypertension and proteinuria, with distinct early- and late-onset forms. Although complement dysregulation has ...

There are two types of complement 3 glomerulopathy: dense deposit disease (DDD) and C3 glomerulonephritis (C3GN). DDD often begins earlier in life and may progress more quickly. Both are linked to an ...